Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- And p38 MAPK-dependent mechanism

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 3, 2009, Pages

  Yusof, Mozow ^a   Kamada, Kazuhiro ^a   Kalogeris, Theodore ^a   Spencer Gaskin, F ^a   Korthuis, Ronald J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Endothelial nitric oxide synthase deficient mice; Ischemia; Leukocyte adhesion; Leukocyte rolling; Reperfusion; Sodium hydrosulfide

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN SULFIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SK 86002; SODIUM DITHIONITE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ENZYME INHIBITOR; NOS3 PROTEIN, MOUSE; SODIUM BISULFIDE; SULFIDE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CONDITIONING; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; HUMAN; HUMAN CELL; ISCHEMIA; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MALE; MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REDUCTION; REGULATORY MECHANISM; REPERFUSION INJURY; SMALL INTESTINE; VENULE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL ADHESION; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INTESTINE; LEUKOCYTE; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION; TIME; VASCULARIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HYDROGEN SULFIDE; INTESTINES; LEUKOCYTE ROLLING; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, VIDEO; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SULFIDES; TIME FACTORS;

EID: 64049088497     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01111.2007     Document Type: Article

References (60)

1. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690, 1992.
3. Armstrong SC. Protein kinase activation and myocardial ischemia/reper- fusion injury. Cardiovasc Res 61: 427-436, 2004.
4. Ballard-Croft C, Kristo G, Yoshimura Y, Reid E, Keith BJ, Mentzer RM, Lasley RD. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments. Am J Physiol Heart Circ Physiol 288: H1359-H1366, 2005.
5. 2- and NO generation in the post-ischemic guinea-pig heart. Cardiovasc Res 63: 118-129, 2004.
6. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316: 670 - 678, 2006.
7. Cheng Y, Ndisang JF, Tang G, Cao K, Wang R. Hydrogen sulfideinduced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287: H2316-H2323, 2004.
8. 1 receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 86: 989-997, 2000.
9. Das S, Otani H, Maulik N, Das DK. Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. J Mol Cell Cardiol 41: 248-255, 2006.
10. Doeller JE, Isbell TS, Benavides G, Koenitzer J, Patel H, Patel RP, Lancaster JR Jr, Darley-Usmar VM, Kraus DW. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem 341: 40-51, 2005.
11. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560 -15565, 2007.
12. Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, Zanardo R, Renga B, Di Sante M, Morelli A, Cirino G, Wallace JL. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129: 1210 -1224, 2005.
13. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42: 539-548, 2005.
14. Fiorucci S, Orlandi S, Mencarelli A, Caliendo G, Santagada V, Distrutti E, Santucci L, Cirino G, Wallace JL. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 150: 996 -1002, 2007.
15. Gaskin FS, Kamada K, Yusof M, Korthuis RJ. 5-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 292: H326-H332, 2007.
16. Geng B, Cui Y, Zhao J, Yu F, Zhu Y, Xu G, Zhang Z, Tang C, Du J. Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol 293: R1608-R1618, 2007.
17. 17a.Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, Tang C. H2S generated by heart in rat and its effect on cardiac function. Biochem Biophys Res Commun 313: 362-368, 2004.
18. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 57: 311-332, 1995.
19. Gute DC, Ishida T, Yarimizu K, Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179: 169-187, 1998.
20. Gute DC, Korthuis RJ. Role of leukocyte adherence in reperfusion- induced microvascular dysfunction and tissue injury. In: Physiology and Pathophysiology of Leukocyte Adhesion, edited by Granger DN and Schmid-Schonbein GW. Oxford, UK: Oxford University Press, 1995, p. 359-380.
21. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531, 1997.
22. Ishida T, Yarimizu K, Gute DC, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 8: 86-94, 1997.
23. Jeon BR, Lee SM. S-adenosylmethionine protects post-ischemic mitochondrial injury in rat liver. J Hepatol 34: 395-401, 2001.
24. Kaiser RA, Bueno OF, Lips DJ, Doevendans PA, Jones F, Kimball TF, Molkentin JD. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemiareperfusion in vivo. J Biol Chem 279: 15524-15530, 2004.
25. Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Acids 26: 243-254, 2004.
26. Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13-19, 2002.
27. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun 267: 129 -133, 2000.
28. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18: 1165-1167, 2004.
29. Koenitzer JR, Isbell TS, Patel HD, Benavides GA, Dickinson DA, Patel RP, Darley-Usmar VM, Lancaster JR Jr, Doeller JE, Kraus DW. Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. Am J Physiol Heart Circ Physiol 292: H1953-H1960, 2007.
30. Korthuis RJ, Dayton C, Yamaguchi T. Early and late preconditioning prevent ischemia/reperfusion injury: signaling pathways mediating the adaptive metamorphosis to a protective phenotype in preconditioned tissues. In: Molecular Mechanisms of Microvascular Disorders, edited by Schmid-Schönbein GW and Granger DN. New York: Springer, 2001.
31. Korthuis RJ, Granger DN, Townsley MI, Taylor AE. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 57: 599-609, 1985.
32. Lochner A, Marais E, Genade S, Huisamen B, Moolman JA. Events downstream of p38MAPK (p38) in ischaemic preconditioning (PC): HSP27 and CREB. CardiovascJSAfr 15: S4-S5, 2004.
33. Marais E, Genade S, Salie R, Huisamen B, Maritz S, Moolman JA, Lochner A. The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning. Basic Res Cardiol 100: 35-47, 2005.
34. Moses MA, Addison PD, Neligan PC, Ashrafpour H, Huang N, Zair M, Rassouli A, Forrest CR, Grover GJ, Pang CY. Mitochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 288: H559-H567, 2005.
35. Ogita H, Liao J. Endothelial function and oxidative stress. Endothelium 11: 123-132, 2004.
36. Okubo S, Xi L, Bernardo NL, Yoshida K, Kukreja RC. Myocardial preconditioning: basic concepts and potential mechanisms. Mol Cell Biochem 196: 3-12, 1999.
37. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 40: 119 -130, 2006.
38. Panes J, Granger DN. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114: 1066-1090, 1998.
39. Peart JN, Gross GJ. Sarcolemmal and mitochondrial KATP channels and myocardial ischemic preconditioning. J Cell Mol Med 6: 453-464, 2002.
40. Rajesh KG, Sasaguri S, Suzuki R, Xing Y, Maeda H. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels. Int J Cardiol 96: 41-49, 2004.
41. Rinaldi L, Gobbi G, Pambianco M, Micheloni C, Mirandola P, Vitale M. Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3. Lab Invest 86: 391-397, 2006.
42. Searcy DG, Whitehead JP, Maroney MJ. Interaction of Cu,Zn superoxide dismutase with hydrogen sulfide. Arch Biochem Biophys 318: 251-263, 1995.
43. Shigematsu S, Ishida S, Gute DC, Korthuis RJ. Postischemic anti- inflammatory effects of bradykinin preconditioning. Am J Physiol Heart Circ Physiol 280: H441-H454, 2001.
44. Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 26: 154-161, 2006.
45. Sohn H, Kuriyama H. The role of amino acids in the regulation of hydrogen sulfide production during ultradian respiratory oscillation of Saccharomyces cerevisiae. Arch Microbiol 176: 69-78, 2001.
46. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, Bolli R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38: 127-134, 2005.
47. Teague B, Asiedu S, Moore PK. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol 137: 139-145, 2002.
48. Wallace JL, Caliendo G, Santagada V, Cirino G, Fiorucci S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide- releasing diclofenac derivative in the rat. Gastroenterology 132: 261-271, 2007.
49. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5: 493-501, 2003.
50. 2S be the third endogenous gaseous transmitter? FASEB J 16: 1792-1798, 2002.
51. ATP channels activated at different time. Chin Med J (Engl) 117: 647-651, 2004.
52. Yamaguchi T, Dayton C, Shigematsu T, Carter P, Yoshikawa T, Gute DC, Korthuis RJ. Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 283: H1019-H1030, 2002.
53. Yamaguchi T, Kamada K, Dayton C, Gaskin FS, Yusof M, Yoshikawa T, Carter P, Korthuis RJ. Role of eNOS-derived NO in the postischemic anti-inflammatory effects of antecedent ethanol ingestion in murine small intestine. Am J Physiol Heart Circ Physiol 292: H1435-H1442, 2007.
54. Yang G, Sun X, Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J 18: 1782-1784, 2004.
55. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte- mediated inflammation. FASEB J 20: 2118-2120, 2006.
56. Zhang H, Zhi L, Moochhala SM, Moore PK, Bhatia M. Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis. J Leukoc Biol 82: 892-905, 2007.
57. Zhao W, Ndisang JF, Wang R. Modulation of endogenous production of H2S in rat tissues. Can J Physiol Pharmacol 81: 848 -853, 2003.
58. Zhao W, Wang R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: H474-H480, 2002.
59. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2Sasa novel endogenous gaseous KATP channel opener. EMBO J 20: 6008 -6016, 2001.
60. Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang SH, Tan CS, Whiteman M, Lu J, Moore PK. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol 102: 261-268, 2007.